CD8A and myeloid sarcoma: As shown in Figure 3, a trend to reduced levels for the three analyzed genes was observed in CD4+ and CD8+ T cells isolated from the MS-affected individuals; however, no statistical significance was reached, probably because of the very limited number of subjects studied (Figure 3).